224 filings
Page 2 of 12
S-8
lc0r5wkh1hz9
10 Aug 23
Registration of securities for employees
4:06pm
8-K
0j5rwly8luvc5gvgm
7 Aug 23
Other Events
7:40am
8-K
proip
3 Aug 23
Collegium Reports Record 1H’23 Net Revenue of $280.3 Million, Up 35% Year-over-Year
4:03pm
8-K
c34 x1y4brod5yd0s
19 May 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
5o1vzktq
4 May 23
Collegium Reports First Quarter 2023 Financial Results
4:01pm
ARS
2mxrwld7s
11 Apr 23
Annual report to shareholders
4:04pm
8-K
byxv3wxjdpu8v56bkawg
23 Feb 23
Collegium Reports Fourth Quarter and Full-Year 2022 Financial Results
4:01pm
8-K
wcgm6
13 Feb 23
Collegium Pharmaceutical, Inc. Prices Upsized $210.0 Million Convertible Senior Notes Offering
4:05pm
8-K
qi8ianw
6 Feb 23
Collegium Announces Fourth Quarter and Full Year 2022 Preliminary Financial Results
4:14pm
8-K
s7uy njnqr8tuu6cfj
4 Jan 23
Regulation FD Disclosure
8:04am
8-K
mbvj5 f5hakqlddw2
22 Dec 22
Appeals Court Affirms Validity of Collegium’s Belbuca® Patents
8:04am
8-K
kbd6ntwriz4
3 Nov 22
Collegium Reports Third Quarter 2022 Financial Results
4:01pm
S-8
79zuqua2rhm5tomoagzb
11 Aug 22
Registration of securities for employees
4:04pm
8-K
sondehn2r etsahde1r
4 Aug 22
Collegium Reports Second Quarter 2022 Financial Results
4:01pm